Tango Therapeutics TNGX Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Tango Therapeutics’s reported figures.
The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tango Therapeutics's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Tango Therapeutics's invested capital?
- Tango Therapeutics (TNGX) reported invested capital of $264.33M in Q1 2026.
- How has Tango Therapeutics's invested capital changed year-over-year?
- Tango Therapeutics's invested capital increased by 85.2% year-over-year, from $142.7M to $264.33M.
- What is the long-term trend for Tango Therapeutics's invested capital?
- Over 5 years (2020 to 2025), Tango Therapeutics's invested capital has grown at a 42.7% compound annual growth rate (CAGR), from $45.18M to $267.47M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).